ECE2010 Oral Communications Reproduction & Thyroid (6 abstracts)
Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model
Erica Gentilin 1 , Fulvia Daffara 2 , Giuseppe Reimondo 2 , Gianni Carandina 3 , Maria Rosaria Ambrosio 1 , Massimo Terzolo 2 , Ettore C degli Uberti 1 & Maria Chiara Zatelli 1
1Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, Italy; 2Division of Internal Medicine I, Department of Clinical and Biological Sciences, Faculty of Medicine San Luigi Gonzaga, University of Turin, Orbassano (TO), Italy; 3Laboratorio Analisi Chimico-Cliniche e Microbiologia, S. Anna Hospital, Ferrara, Italy.
Mitotane therapy is associated with many side effects, including thyroid function perturbations mimicking central hypothyroidism, possibly due to laboratory test interference or pituitary direct effects of mitotane. Therefore, we aimed at investigating whether increasing concentrations of mitotane in the therapeutic range might interfere with thyroid hormone assays and evaluate the effects of mitotane on a mouse TSH- producing pituitary cell line. TSH, FT4 and FT3 levels do not significantly change in sera from hypo-, hyper- or euthyroid patients after addition of mitotane at concentrations in the therapeutic window. In the mouse TαT1 cell line mitotane inhibits both TSH expression and secretion, blocks TSH response to TRH and reduces cell viability, inducing apoptosis at concentrations in the therapeutic window. TRH is not capable of rescuing TαT1 cells from the inhibitory effects of mitotane on TSH expression and secretion, that appear after short time treatment and persist over time. Our results demonstrate that mitotane does not interfere with thyroid hormone laboratory tests but directly reduces both secretory activity and cell viability on pituitary TSH-secreting mouse cells. These data represent a possible explanation of the biochemical picture consistent with central hypothyroidism in patients undergoing mitotane therapy, and open new perspectives on the direct pituitary effects of this drug.
Volume 22
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more